Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
February 9-10, 2015 - The Waldorf Astoria, New York City, US
November 24-26, 2014 - Frankfurt-am-Main - Germany
November 5, 2014 - Zürich, Switzerland